Learn More
SARS-CoV-2 Spike RBD Antibody, R&D Systems™
Mouse Monoclonal Antibody
Brand: R&D Systems MAB11290-SP
Description
Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples. It is validated for Blocking Assay, Neutralization
Specifications
Spike RBD | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. | |
IgG2b |
Blocking Assay, Neutralization | |
1049865 | |
Blockade of Receptor-ligand Interaction, Neutralization | |
P0DTC2 | |
Human embryonic kidney cell, HEK293-derived SARS-CoV2 SARS-CoV2 spike, Arg319-Phe541, Accession # P0DTC2 | |
25 μg | |
Primary | |
SARS-CoV-2 | |
Purified |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.